Publicacions en què col·labora amb Andrés Íñiguez Romo (5)

2022

  1. Avances tecnológicos en el tratamiento de las enfermedades cardiovasculares: perspectiva de médicos y administradores

    REC: Interventional Cardiology, Vol. 4, Núm. 3, pp. 243-245

  2. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386

2012

  1. Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 2, pp. 125-130